Novartis AG Common Stock (NVS)

Operating Expenses

$6.00B

Quarterly · Period ending: · USD

NVS logo

NVS Operating Expenses

Latest reported$6.00B
NVS Quarterly Operating Expenses ($5.70B → $6.00B)
High-resolution chart · PNG

NVS operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
6,002,111,000
5,830,000,000
6,272,523,000
6,318,000,000
6,650,000,000
5,730,000,000
6,704,000,000
6,311,000,000
5,685,000,000
5,651,000,000
6,172,000,000
7,213,000,000
5,596,000,000
5,438,000,000
7,065,000,000
6,083,000,000
7,106,000,000
6,106,000,000
6,984,000,000
6,196,000,000
5,901,000,000
6,240,000,000
6,169,000,000
6,373,000,000
5,841,000,000
6,242,000,000
6,901,000,000
6,348,000,000
5,955,000,000
5,962,000,000
7,439,000,000
5,684,000,000
5,664,000,000
5,341,000,000
6,605,000,000
6,012,000,000
5,956,000,000
5,758,000,000
6,662,000,000
5,704,000,000
6,135,000,000
5,147,000,000
6,578,000,000
5,863,000,000
6,128,000,000
5,437,000,000
6,587,000,000
6,140,000,000
6,387,000,000
6,086,000,000
7,678,000,000
6,222,000,000
6,160,000,000
6,704,000,000
7,500,000,000
6,516,000,000
6,823,000,000
6,693,000,000
8,561,000,000
7,295,000,000
7,182,000,000
6,356,000,000
7,473,000,000
6,571,000,000
5,754,000,000
5,749,000,000
6,841,000,000
5,553,000,000
5,554,000,000
4,771,000,000
5,834,000,000
5,674,000,000
5,593,000,000
5,080,000,000
6,851,000,000
4,742,000,000
4,674,000,000
4,551,000,000
5,206,000,000
4,516,000,000
4,055,000,000
3,910,000,000
4,748,000,000
4,151,000,000
4,046,000,000
3,808,000,000
4,162,000,000
3,727,000,000
3,585,000,000
3,609,000,000
3,516,000,000
3,241,000,000
3,317,000,000
3,007,000,000
4,157,000,000
2,606,000,000
2,859,000,000
4,858,000,000
5,138,000,000
5,576,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.